Rapid Micro Biosystems (RPID) Price to Sales (2021 - 2026)

Rapid Micro Biosystems has disclosed Price to Sales across 6 years of filings, most recently posting 9.77 for Q2 2026.

• In Q2 2026, Price to Sales fell 48.04% year-over-year to 9.77; the TTM figure through Jun 2026 stood at 2.24 (down 50.38% YoY), while the FY2025 annual figure was 3.45, up 185.1% from the prior year.
• Price to Sales came in at 9.77 for Q2 2026 at Rapid Micro Biosystems, down from 11.71 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 59.39 in Q1 2022 to a low of 3.75 in Q2 2024.
• Average Price to Sales over 5 years is 14.59, with a median of 9.67 recorded in 2026.
• Year-over-year, Price to Sales tumbled 88.86% in 2022 and surged 401.25% in 2025.
• Over 5 years, Price to Sales stood at 9.44 in 2022, then plunged by 54.1% to 4.33 in 2023, then slipped by 4.63% to 4.13 in 2024, then jumped by 148.66% to 10.27 in 2025, then retreated by 4.95% to 9.77 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 9.77 in Q2 2026, 11.71 in Q1 2026, and 10.27 in Q4 2025.